Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis - Novel insights and future directions in diagnosis and therapy

被引：124
作者：
Hartley, Adam [1 ]
Haskard, Dorian [1 ]
Khamis, Ramzi [1 ]
机构：
[1] Imperial Coll London, Natl Heart & Lung Inst, Hammersmith Hosp Campus,Cane Road, London W12 0NN, England
来源：
TRENDS IN CARDIOVASCULAR MEDICINE | 2019年 / 29卷 / 01期
关键词：
Oxidized low-density lipoprotein; Atherosclerosis; Vulnerable plaque; LOW-DENSITY-LIPOPROTEIN; OXIDATION-SPECIFIC EPITOPES; APOLIPOPROTEIN B-100; IMMUNE-COMPLEXES; CARDIOVASCULAR EVENTS; IGM AUTOANTIBODIES; MDA-LDL; CORONARY; BIOMARKERS; DISEASE;
D O I：
10.1016/j.tcm.2018.05.010
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We provide an up-to-date overview of current topics surrounding oxidized low-density lipoprotein (oxLDL) and its related antibodies in the quest to better identify the individuals at risk of cardiovascular disease and atherosclerotic plaques with unfavorable characteristics. We discuss the potential of oxLDL and anti-oxLDL antibodies as serum biomarkers of cardiovascular disease and emerging studies examining the targeting of arterial oxLDL for imaging and therapeutic delivery. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码：22 / 26
页数：5
相关论文
共 50 条
  • [31] Effect of Simvastatin on the Generation of Autoantibodies Against Oxidized LDL and Progression of Atherosclerosis in Rabbits
    Cavallini, Daniela C. U.
    Abdalla, Dulcineia S. P.
    Pauly-Silveira, Nadiege D.
    Rossi, Elizeu A.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2010, 29 (08): : 1419 - 1424
  • [32] Transient Increase in Plasma Oxidized LDL During the Progression of Atherosclerosis in Apolipoprotein E Knockout Mice
    Kato, Rina
    Mori, Chihiro
    Kitazato, Keiko
    Arata, Satoru
    Obama, Takashi
    Mori, Masahiro
    Takahashi, Katsuhiko
    Aiuchi, Toshihiro
    Takano, Tatsuya
    Itabe, Hiroyuki
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (01) : 33 - U82
  • [33] Association of anti-oxidized LDL and candidate genes with severity of coronary stenosis in the Women's Ischemia Syndrome Evaluation study
    Chen, Qi
    Reis, Steven E.
    Kammerer, Candace
    Craig, Wendy
    McNamara, Dennis M.
    Holubkov, Richard
    Sharaf, Barry L.
    Sopko, George
    Pauly, Daniel F.
    Merz, C. Noel Bairey
    Kamboh, M. Ilyas
    JOURNAL OF LIPID RESEARCH, 2011, 52 (04) : 801 - 807
  • [34] Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL with statin therapy
    Vasankari, T
    Ahotupa, M
    Toikka, J
    Mikkola, J
    Irjala, K
    Pasanen, P
    Neuvonen, K
    Raitakari, O
    Viikari, J
    ATHEROSCLEROSIS, 2001, 155 (02) : 403 - 412
  • [35] Discrimination between minimally modified LDL and fully oxidized LDL using monoclonal antibodies
    Lowhalidanon, Kanokwan
    Khunkaewla, Panida
    ANALYTICAL BIOCHEMISTRY, 2021, 619
  • [36] Assessment of IgG antibodies to oxidized LDL in patients with acute coronary syndrome
    Laczik, R.
    Szodoray, P.
    Veres, K.
    Szomjak, E.
    Csipo, I.
    Sipka, S., Jr.
    Shoenfeld, Y.
    Szekanecz, Z.
    Soltesz, P.
    LUPUS, 2011, 20 (07) : 730 - 735
  • [37] Atherosclerosis and sensitive determination of oxidized LDL using monoclonal antibody
    Itabe, H
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2002, 122 (10): : 745 - 753
  • [38] Antibodies to oxidized LDL in relation to carotid atherosclerosis, cell adhesion molecules, and phospholipase A2
    Hulthe, J
    Wiklund, O
    Hurt-Camejo, E
    Bondjers, G
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (02) : 269 - 274
  • [39] Antibodies against oxidized LDL and atherosclerosis in rheumatoid arthritis patients treated with biological agents: a prospective controlled study
    Papamichail, G. V.
    Georgiadis, A. N.
    Tellis, C. C.
    Rapti, I.
    Markatseli, T. E.
    Xydis, V. G.
    Tselepis, A. D.
    Drosos, A. A.
    Voulgari, P. V.
    CLINICAL RHEUMATOLOGY, 2024, 43 (01) : 481 - 488
  • [40] Novel oxidized LDL-based clinical markers in peritoneal dialysis patients for atherosclerosis risk assessment
    Papadea, Polyxeni
    Kalaitzopoulou, Electra
    Skipitari, Marianna
    Varemmenou, Athina
    Papasotiriou, Marios
    Papachristou, Evangelos
    Goumenos, Dimitrios
    Grune, Tilman
    Georgiou, Christos D.
    REDOX BIOLOGY, 2023, 64
12345